Related references
Note: Only part of the references are listed.European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2021)
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
Antonio Lopez-Beltran et al.
CANCERS (2021)
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
Tibor Szarvas et al.
DIAGNOSTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Sia Viborg Lindskrog et al.
NATURE COMMUNICATIONS (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Iliana K. Kerzeli et al.
PLOS ONE (2021)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort
Chad R. Ritch et al.
JOURNAL OF UROLOGY (2020)
Sex differences in cancer mechanisms
Joshua B. Rubin et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility
Douglas G. Ward et al.
EUROPEAN UROLOGY (2020)
Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma
Zhaohui Chen et al.
NATURE COMMUNICATIONS (2020)
NKG2D and MICA/B shedding: a 'tag game' between NK cells and malignant cells
Samantha Xing et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment
Madhuri Koti et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
Dongkui Song et al.
JOURNAL OF PATHOLOGY (2019)
A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting
Laleh Sharifi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
Hangcheng Fu et al.
CLINICAL CANCER RESEARCH (2018)
Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles
Saeed Daneshmandi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
Christian Bolenz et al.
BLADDER CANCER (2018)
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
H. Zhang et al.
ONCOGENE (2017)
Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer
Guoliang Yang et al.
ONCOTARGET (2017)
Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer (Publication with Expression of Concern. See vol. 12, pg. 733, 2019)
Feng Jin et al.
CANCER PREVENTION RESEARCH (2017)
Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
Rianne J. M. Lammers et al.
WORLD JOURNAL OF UROLOGY (2016)
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
Fee Klupp et al.
BMC CANCER (2016)
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review
Michele Marchioni et al.
CLINICAL GENITOURINARY CANCER (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
T. Hemdan et al.
BRITISH JOURNAL OF CANCER (2014)
The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Gui Han Lee et al.
CURRENT CANCER DRUG TARGETS (2014)
The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure
Luis Lima et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Soluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor Immunity
Jianping Huang et al.
JOURNAL OF IMMUNOLOGY (2013)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma
Kevin Tak-Pan Ng et al.
EUROPEAN JOURNAL OF CANCER (2011)
Matrix metalloproteinases and their clinical relevance in urinary bladder cancer
Tibor Szarvas et al.
NATURE REVIEWS UROLOGY (2011)
Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood
Martin Lundberg et al.
NUCLEIC ACIDS RESEARCH (2011)
The West Midlands Bladder Cancer Prognosis Programme: rationale and design
Maurice P. Zeegers et al.
BJU INTERNATIONAL (2010)
A Multiplexed, Particle-Based Flow Cytometric Assay Identified Plasma Matrix Metalloproteinase-7 to Be Associated With Cancer-Related Death Among Patients With Bladder Cancer
Robert S. Svatek et al.
CANCER (2010)
Increased Infiltration of Tumor Associated Macrophages is Associated With Poor Prognosis of Bladder Carcinoma In Situ After Intravesical Bacillus Calmette-Guerin Instillation
Hitoshi Takayama et al.
JOURNAL OF UROLOGY (2009)
RANDOM SURVIVAL FORESTS
Hemant Ishwaran et al.
ANNALS OF APPLIED STATISTICS (2008)
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
P. M. McGowan et al.
ANNALS OF ONCOLOGY (2008)
Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness
A. Karim Kader et al.
CLINICAL CANCER RESEARCH (2007)
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
MJ Wallard et al.
BRITISH JOURNAL OF CANCER (2006)
Carcinogen exposure and gene promoter hypermethylation in bladder cancer
CJ Marsit et al.
CARCINOGENESIS (2006)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Prognostic value of tumor-associated macrophage count in human bladder cancer
T Hanada et al.
INTERNATIONAL JOURNAL OF UROLOGY (2000)
Share Paper
